Search

Your search keyword '"Phoenix DA"' showing total 163 results

Search Constraints

Start Over You searched for: Author "Phoenix DA" Remove constraint Author: "Phoenix DA"
163 results on '"Phoenix DA"'

Search Results

1. Delivery of anticancer molecules using carbon nanotubes

6. Conventional Antibiotics – Revitalized by New Agents

7. Bacterial susceptibility and resistance to modelin-5.

8. Temporin B Forms Hetero-Oligomers with Temporin L, Modifies Its Membrane Activity, and Increases the Cooperativity of Its Antibacterial Pharmacodynamic Profile.

9. PEGylation enhances the antibacterial and therapeutic potential of amphibian host defence peptides.

10. Antimicrobial Peptides with pH-Dependent Activity and Alkaline Optima: Their Origins, Mechanisms of Action and Potential Applications.

11. Linearized esculentin-2EM shows pH dependent antibacterial activity with an alkaline optimum.

12. Impacts of Metabolism and Organic Acids on Cell Wall Composition and Pseudomonas aeruginosa Susceptibility to Membrane Active Antimicrobials.

13. A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy.

14. Biophysical studies on the antimicrobial activity of linearized esculentin 2EM.

15. Temporin L and aurein 2.5 have identical conformations but subtly distinct membrane and antibacterial activities.

16. Liposome mediated-CYP1A1 gene silencing nanomedicine prepared using lipid film-coated proliposomes as a potential treatment strategy of lung cancer.

17. Biophysical investigation into the antibacterial action of modelin-5-NH 2 .

18. Minor sequence modifications in temporin B cause drastic changes in antibacterial potency and selectivity by fundamentally altering membrane activity.

19. Ethanol-based proliposome delivery systems of paclitaxel for in vitro application against brain cancer cells.

20. An Atlas of Anionic Antimicrobial Peptides from Amphibians.

21. Investigations into the potential anticancer activity of Maximin H5.

22. pH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic Agents.

23. Low pH Enhances the Action of Maximin H5 against Staphylococcus aureus and Helps Mediate Lysylated Phosphatidylglycerol-Induced Resistance.

24. The effect of amidation on the behaviour of antimicrobial peptides.

25. Anionic Host Defence Peptides from the Plant Kingdom: Their Anticancer Activity and Mechanisms of Action.

26. Prediction of Peptide and Protein Propensity for Amyloid Formation.

27. The increasing role of phosphatidylethanolamine as a lipid receptor in the action of host defence peptides.

28. The role of C-terminal amidation in the membrane interactions of the anionic antimicrobial peptide, maximin H5.

29. A facile approach to manufacturing non-ionic surfactant nanodipsersions using proniosome technology and high-pressure homogenization.

30. PEGylated graphene oxide for tumor-targeted delivery of paclitaxel.

31. Stability of parenteral nanoemulsions loaded with paclitaxel: the influence of lipid phase composition, drug concentration and storage temperature.

32. The cooperative behaviour of antimicrobial peptides in model membranes.

33. Thymopentin nanoparticles engineered with high loading efficiency, improved pharmacokinetic properties, and enhanced immunostimulating effect using soybean phospholipid and PHBHHx polymer.

34. Investigation into the potential for hypoxic interior of neoplasms to enhance HSPA expression in glioma.

35. Susceptibility of sheep, human, and pig erythrocytes to haemolysis by the antimicrobial peptide Modelin 5.

36. Reliability of HSP70 (HSPA) expression as a prognostic marker in glioma.

37. Using sound for microbial eradication--light at the end of the tunnel?

38. Sounding the death knell for microbes?

39. The interaction of aurein 2.5 with fungal membranes.

40. The effects of suspension particle size on the performance of air-jet, ultrasonic and vibrating-mesh nebulisers.

41. A study of the effects of sodium halides on the performance of air-jet and vibrating-mesh nebulizers.

42. A novel form of bacterial resistance to the action of eukaryotic host defense peptides, the use of a lipid receptor.

43. Antimicrobial activity of aurein 2.5 against yeasts.

44. Insights into the molecular mechanism of protein native-like aggregation upon glycation.

45. Synthetic oligoureas of metaphenylenediamine mimic host defence peptides in their antimicrobial behaviour.

46. Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology.

47. Aurein 2.3 functionality is supported by oblique orientated α-helical formation.

48. On the selectivity and efficacy of defense peptides with respect to cancer cells.

49. Role of molecular architecture on the relative efficacy of aurein 2.5 and modelin 5.

50. Effect of salt on the interaction of Hal18 with lipid membranes.

Catalog

Books, media, physical & digital resources